Based on the results of the PPI network diagram analysis, it is evident that targets such as IL-6, PTGS2, TNF, VEGFA, CCL2, IL-1B, CXCL8, CASP3, MPO, and IL-10 are potential key targets of SGD in the treatment of AA. Here, PTGS2 is linked to specific granule deficiency.